NCT05346250

Brief Summary

Our previous randomized controlled trial has recruited 220 subjects with central obesity and allocated the subjects to the non-exercise control, moderate exercise and vigorous exercise groups. The purpose of our previous study was to investigate the effect of moderate and vigorous exercise on improvement of fatty liver. Those subjects will be followed up for incident diabetes at 2 year and 10 year since randomization. The subjects will be invited to participate in on-site visit at 2 and 10 year. Questionaire forms will be collected and fasting plasma glucose level and HbA1c were measured. The history of diabetes and anti-diabetic medication will be recorded. The incident diabetes will be evaluated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
10.8 years until next milestone

First Submitted

Initial submission to the registry

April 20, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 26, 2022

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

June 7, 2023

Status Verified

June 1, 2023

Enrollment Period

10.9 years

First QC Date

April 20, 2022

Last Update Submit

June 5, 2023

Conditions

Keywords

Type 2 DiabetesObesity

Outcome Measures

Primary Outcomes (1)

  • Incidence of type 2 diabetes

    The occurrence of diabetes at 2- and 10-year follow-up

    10 years since randomization

Secondary Outcomes (3)

  • Body weight change

    10 years since randomization

  • Blood pressure change

    10 years since randomization

  • Serum lipid change

    10 years since randomization

Study Arms (3)

Non exercise program

Subjects receive 12 month lifestyle education alone.

Behavioral: Non-exercise control

Moderate intensity exercise program

Subjects receive 12 month moderate exercise.

Behavioral: Moderate intensity exercise

Vigorous intensity exercise program

Subjects receive 6 month vigorous exercise and subsequent 6 month moderate exercise

Behavioral: Vigorous intensity exercise

Interventions

12 month lifestyle education

Non exercise program

12 month moderate intensity exercise by brisk walk 30 min per day and more than 5 days per week.

Moderate intensity exercise program

6 month vigorous intensity exercise on treadmill for 30 min per day and more than 5 days per week, and subsequent 6 month moderate exercise by brisk walk 30 min per day and more than 5 days per week.

Vigorous intensity exercise program

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The participants in our study included all subjects who had been enrolled in the previous randomized controlled trial.

You may qualify if:

  • Subjects with NAFLD determined by 1H MRS (intrahepatic triglyceride content ≥5%);
  • years old;
  • Waist circumference \>90cm for men and \>85cm for women

You may not qualify if:

  • Consumed more than an average of 140 grams of ethanol (10 alcoholic drinks) per week in men and 70 grams of ethanol (five drinks) in women during the past six months;
  • A history of acute or chronic viral hepatitis, drug-induced liver diseases, and autoimmune hepatitis;
  • Myocardial infarction in the past six months;
  • Biliary obstructive diseases;
  • Uncontrolled hypertension (i.e. systolic BP\>180 mmHg, and/or diastolic DBP \>100 mmHg);
  • Chronic kidney disease (serum creatinine ≥1.5 mg/dL in men and ≥1.3 mg/dL in women);
  • Heart failure (New York Heart Association III or IV);
  • Currently participating in weight loss programs;
  • Currently pregnant or planning to be pregnant;
  • Having any medical condition that would affect metabolism (i.e. diabetes, known hyperthyroidism or hypothyroidism);
  • Having a medical condition that would limit exercise participation and taking medication that would affect metabolism or weight loss (i.e. thyroid medication and glucocorticoids) or would alter the heart rate response during exercise (i.e. β-blockers);
  • Unable to participate in the follow-up examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Zhang HJ, He J, Pan LL, Ma ZM, Han CK, Chen CS, Chen Z, Han HW, Chen S, Sun Q, Zhang JF, Li ZB, Yang SY, Li XJ, Li XY. Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. JAMA Intern Med. 2016 Aug 1;176(8):1074-82. doi: 10.1001/jamainternmed.2016.3202.

  • Zhang HJ, Pan LL, Ma ZM, Chen Z, Huang ZF, Sun Q, Lu Y, Han CK, Lin MZ, Li XJ, Yang SY, Li XY. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study. Diabetes Obes Metab. 2017 Feb;19(2):284-289. doi: 10.1111/dom.12809. Epub 2016 Nov 22.

  • Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, Han HW, Han CK, Zhuang XJ, Lu Y, Li XJ, Yang SY, Li XY. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013 Sep;59(3):557-62. doi: 10.1016/j.jhep.2013.04.030. Epub 2013 May 9.

  • Chen Y, Chen Z, Pan L, Ma ZM, Zhang H, Li XJ, Li X. Effect of Moderate and Vigorous Aerobic Exercise on Incident Diabetes in Adults With Obesity: A 10-Year Follow-up of a Randomized Clinical Trial. JAMA Intern Med. 2023 Mar 1;183(3):272-275. doi: 10.1001/jamainternmed.2022.6291.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Obesity, AbdominalObesity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Xiaoying Li, MD

    Fudan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 20, 2022

First Posted

April 26, 2022

Study Start

July 1, 2011

Primary Completion

May 15, 2022

Study Completion

May 30, 2022

Last Updated

June 7, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will share

deidentified data will be available after approval of the proposal

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
2023-01\~2025-01